I am very impressed with this idea and the thoughtfulness that has clearly been demonstrated in the responses to all of the questions that have been posted. The value of this model is quite clear for populations that have limited access to pharmaceuticals right now. For people who are currently accessing "medicines" from the unregulated shops, there may be different challenges at play. What are your thoughts on competing with the unregulated shops? Is there where you would see potential subsidy models being advantageous?